CEVEC’s CAP Go derived recombinant placental human alkaline phosphatase (PLAP) shows promise
6 July 2015 | By Victoria White
CEVEC Pharmaceuticals has announced results of a preclinical study in which CAP Go derived recombinant PLAP showed significantly prolonged serum-half-life...